ArticleOncology reports2026

Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma.

Daniel Zezulinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.